Sanjay Maraboyina

Associate Professor

UAMS

Also affiliated: Christian Medical College, Vellore (2011); University of Kansas Medical Center (2011); University of Cincinnati (2006)

Radiation Oncology, College of Medicine

9 h-index 29 pubs 261 cited

Research Areas

Biomedical Subjects

Links

Research Group UAMS TRI Profile

OverviewAI-generated summary

Dr. Sanjay Maraboyina's research focuses on radiation oncology, with a specific interest in treatment planning and delivery. His work includes studies on robust optimization in lung cancer treatment plans to account for geometric uncertainty and dose falloff gradient analysis in stereotactic body radiation therapy. He has also investigated therapeutic benefits of grid irradiation on Tomotherapy for resistant tumors. Dr. Maraboyina has explored the role of poly(ADP-ribose) polymerase inhibitors in cancer treatment and methods to overcome resistance. His research also extends to the epidemiology and surgical treatment of urethral clear cell carcinoma and the effects of post-mastectomy radiation therapy on survival in breast cancer patients. He has published 29 works, accumulating 260 citations and an h-index of 9. His collaborations include work with researchers at the University of Arkansas for Medical Sciences and the University of Arkansas at Fayetteville.

Research Overview

Dr. Sanjay Maraboyina is an Assistant Professor in the Radiation Oncology Department at the UAMS College of Medicine, and is board certified by the American Board of Radiology. He received his medical degree from Drexel University College of Medicine. Dr. Maraboyina went on to complete an internship in internal medicine at Christ Hospital in Cincinnati, Ohio and a Radiation Oncology residency at the University of Kansas Medical Center. He also completed a Prostate Brachytherapy Scholarship at the MD Anderson Cancer Center in Houston.Dr. Maraboyina has done research work on a number of topics, including the effects of brachytherapy for prostate cancer and the effects of insulin and glucocorticoids on the cell cycle. His publications include abstracts in the International Journal of Radiation Oncology, the official journal of the American Society for Radiation Oncology (ASTRO), as well as presenting an abstact at the American Society of Hematology Annual Meeting.

Metrics

h-index: 9
Publications: 29
Citations: 261

Positions

Associate Professor publications 2016–2022

University of Arkansas for Medical Sciences Radiation Oncology, College of Medicine Institutional directory

Selected Publications

Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial (2026)

The Lancet DOI OpenAlex
Spectral CT Imaging for the Visualization of Hyaluronic Acid Based Rectal Spacers prior to Radiation Therapy (2024)

International Journal of Radiation Oncology*Biology*Physics DOI OpenAlex
Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable Cancer (2024)

Journal of Clinical Medicine 2 citations DOI OpenAlex
Stem Cell Theory of Cancer: Clinical Implications for Cellular Metabolism and Anti-Cancer Metabolomics (2024)

Cancers 4 citations DOI OpenAlex
Stem Cell Origin of Cancer: Clinical Implications for Cancer Immunity and Immunotherapy (2023)

Cancers 2 citations DOI OpenAlex
A Prospective Study Measuring Resident and Faculty Contour Concordance: A Potential Tool for Quantitative Assessment of Residents’ Performance in Contouring and Target Delineation in Radiation Oncology Residency (2023)

Journal of the American College of Radiology 6 citations DOI OpenAlex
Stem Cell Origin of Cancer: Implications of Oncogenesis Recapitulating Embryogenesis in Cancer Care (2023)

Cancers 6 citations DOI OpenAlex
Cleaning the dose falloff with low modulation in SBRT lung plans (2023)

Biomedical Physics & Engineering Express 2 citations DOI OpenAlex
A Prospective Study Measuring Resident/Faculty Contour Concordance: A Potential Tool for Quantitative Assessment of Residents’ Performance in Contouring and Target Delineation (2023)

medRxiv 1 citation DOI OpenAlex
Analysis of Resident/Faculty Contour Concordance: A Potential Tool for Quantitative Assessment of Residents’ Performance in Target Volume Delineation (2022)

International Journal of Radiation Oncology*Biology*Physics DOI OpenAlex
Facilitators and barriers to employment for rural women cancer survivors (2022)

Journal of Cancer Survivorship 15 citations DOI OpenAlex
Health care disparities and barriers to palliative care among metastatic renal cell carcinoma patients: An NCDB analysis. (2021)

Journal of Clinical Oncology 3 citations DOI OpenAlex
Brachytherapy vs external beam therapy among NSCLC patients undergoing limited surgical resection (2020)

Journal of Cancer Research and Clinical Oncology 3 citations DOI OpenAlex
The Role of Radiotherapy Among Patients With Prostate Ductal Adenocarcinoma (2020)

Clinical Genitourinary Cancer 4 citations DOI OpenAlex
SBRT versus nephrectomy in the treatment of renal cell carcinoma. (2020)

Journal of Clinical Oncology DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

As listed on this researcher's institutional profile.

Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (PREDICT-RT*) (273360) NRG Oncology Foundation Principal Investigator
NRG-GU012 - Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI) NRG Oncology Foundation Principal Investigator
297182 Title NRG-GU013, “The Phase III ‘High Five Trial’ Five Fraction Radiation For High-Risk Prostate Cancer” NRG Oncology Foundation Principal Investigator